Pathology in Biotech and Industry is a new community within the membership of the American Society for Investigative Pathology (ASIP) that is engaged in the science and focused on the issues that face pathologists, scientists, technicians, and those in training who are working in or considering working in the biotech and pharmaceutical industries.
Our two-fold mission includes:
- providing a forum for showcasing new and developing scientific findings, methods, technologies, and tools from the worlds of biotechnology and drug development, and
- establishing a community committed to recognizing members’ scientific achievements and devoted to fostering the development and advancement of pathology careers in the biotechnology and pharmaceutical industries.
Pathology in Biotech and Industry will provide innovative opportunities for productive networking, development of meaningful professional partnerships, and mentoring.
Dr. Cary Austin
Genentech Research Pathology
Dr. Shawn O’Neil
Pfizer Global Pathology & Investigative Toxicology
ASIP members from any membership category (Regular, NextGen, Trainee, etc.) who are involved in the biotechnology & pharmaceutical industries or those interested in opportunities in industry are eligible for membership and encouraged to join. If you are a current ASIP member and would like to join, please email Lisa McFadden. Otherwise, you can elect to join Pathology in Biotech and Industry when you renew your membership. Pathology in Biotech and Industry will have a presence on the ASIP website and will contribute to our scientific meetings by co-organizing scientific sessions (in conjunction with various Scientific Interest Groups), as well as educational and career development events (in conjunction with the Committee for Career Development and the Education Committee). We also look forward to the development of various programs to recognize the research achievements and promote career progression of ASIP members affiliated with Pathology in Biotech and Industry SIG.